Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Investigate the Safety and Efficacy of a Recombinant Human Parathyroid Hormone, for the Treatment of Adults With Hypoparathyroidism (RELAY)

This study has been completed.
Information provided by (Responsible Party):
NPS Pharma Identifier:
First received: December 28, 2010
Last updated: October 1, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 21, 2012